Disease / condition
NSCLC clinical trials
Free access to 296 studies10+ countriesUpdated daily102 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
296
Total trials
10+
Countries
10+
Sponsors
102
Recruiting
By phase
N/A93
Phase 276
Phase 132
Phase 331
Early Phase 124
By status
Recruiting102
Completed70
Not yet recruit...65
Unknown35
Terminated9
Top countries
China144
Japan16
United States of America11
Netherlands10
South Korea10
Top sponsors
AstraZeneca7
Shanghai Chest Hos...6
Novartis Pharma Se...5
The Netherlands Ca...5
Allist Pharmaceuti...4
Recent trials
Latest clinical trials for NSCLC
Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation
National Cancer Center, China
NCT06414915Not yet recr...
- Phase
- Phase 2
A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients
Sunshine Guojian Pharmaceutica... · China
NCT06361927Recruiting
- Phase
- Phase 2
A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations
National Cancer Center, China
NCT06362980Not yet recr...
- Phase
- Phase 1
A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis
Jiangsu Province Nanjing Brain... · China
NCT06339242Recruiting
- Phase
- Phase 2
Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer
The Netherlands Cancer Institu...
NCT06329648Not yet recr...
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC
Taixing People's Hospital · China
NCT06328049Recruiting
- Phase
- Phase 2
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis
Jiangsu Province Nanjing Brain... · China
NCT06332287Recruiting
- Phase
- Phase 2
An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC
Jiangsu Province Nanjing Brain... · China
NCT06332300Recruiting
- Phase
- Phase 2
Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy
Cancer Institute and Hospital,... · China
NCT06317558Recruiting
The Dynamic Monitoring of Cerebrospinal Fluid ctDNA
Jiangsu Province Nanjing Brain... · China
NCT06315686Recruiting
- Phase
- Phase 2
A Phase 2 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Patients With Stage 4 Non-Small Cell Lung Cancer
Eikon Therapeutics · United States of America
NCT06246110Recruiting
- Phase
- Phase 2
Korean Registry of Non-Small Cell Lung Cancer Patients With EGFR Mutation
Yuhan Corporation · South Korea
NCT06247280Recruiting
Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects
TYK Medicines, Inc · China
NCT06255951Recruiting
- Phase
- Phase 1
Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations (EGFR or ALK)
Tianjin Medical University Can...
NCT06221670Not yet recr...
- Phase
- Phase 2
Immuno-pet iMaging resPonses administeRed Immune checkpoiNt inhibiTor
Radboud University Medical Cen... · Germany,Netherlands
NCT06218069Not yet recr...
- Phase
- Phase 2/3
A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer
Northern Jiangsu Province Peop... · China
NCT06108726Recruiting
- Phase
- Phase 2
Progression-free, disease-free, and recurrence-free survivals as surrogate in NSCLC perioperative chemotherapy trials
Yokohama City University Hospi... · Japan
UMIN000052558Not yet recr...
Safety and Efficacy of NK510 to Treat NSCLC
Base Therapeutics (Shanghai) C... · China
NCT06097962Recruiting
- Phase
- Phase 1
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb · Argentina,Chile,Italy,Poland,Romania,United States of America
NCT06094296Not yet recr...
- Phase
- Phase 2
Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens
University of Milano Bicocca · Italy
NCT06050278Recruiting
About this profile
Access comprehensive clinical trial information for NSCLC through Pure Global AI's free database. This collection includes 296 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 102 trials are actively recruiting participants.
Research for NSCLC is being conducted in China, Japan, United States of America and 7+ other countries. Leading sponsors include AstraZeneca and Shanghai Chest Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 296 clinical trials studying NSCLC, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AstraZeneca, Shanghai Chest Hospital, Novartis Pharma Services Inc., among others.